Individualized methotrexate dosing in primary CNS lymphoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2010.66.pdf
Reference7 articles.
1. Morris, P. G. & Abrey, L. E. Therapeutic challenges in primary CNS lymphoma. Lancet Neurol. 8, 581–592 (2009).
2. Ferreri, A. J. et al. Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas. Br. J. Cancer 90, 353–358 (2004).
3. Joerger, M. et al. Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: a pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial. Br. J. Cancer 102, 673–677 (2010).
4. Ferreri, A. J. et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 374, 1512–1520 (2009).
5. Zelcer, S. et al. Methotrexate levels and outcome in osteosarcoma. Pediatr. Blood Cancer 44, 638–642 (2005).
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diagnosis and management of primary central nervous system lymphoma: a Consensus Practice Statement from the Australasian Lymphoma Alliance;Internal Medicine Journal;2021-12-19
2. Optimal dose and uncertainty estimation for individualized drug administration using pharmacokinetic models;Computers & Chemical Engineering;2021-10
3. A minimal physiologically based pharmacokinetic model for high-dose methotrexate;Cancer Chemotherapy and Pharmacology;2021-06-13
4. Addition of low dose acetazolamide as an adjunct in patients undergoing high dose methotrexate is safe and beneficial;Internal Medicine Journal;2020-03
5. Application of a Pharmacokinetic Model to Inform the Optimal Dose for Individualized Drug Administration;Computer Aided Chemical Engineering;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3